Mayo v. Prometheus: The Ultimate Guide to Patenting Laws of Nature

LEGAL DISCLAIMER: This article provides general, informational content for educational purposes only. It is not a substitute for professional legal advice from a qualified attorney. Always consult with a lawyer for guidance on your specific legal situation.

Imagine you're a brilliant meteorologist who discovers a fundamental truth of nature: whenever a specific type of high-altitude cirrus cloud appears, it will rain in exactly 60 minutes. This is a groundbreaking discovery, a “law of nature.” Thrilled, you try to get a patent on the *idea* of “observing that cloud, and then knowing it will rain.” The U.S. government would reject your patent. You can't own a fact of nature any more than you can patent the law of gravity. But what if you then invent a brand-new, complex radar system that automatically detects that specific cloud, cross-references it with atmospheric pressure data, and then activates a city-wide network of public umbrellas? Your patent claim is no longer just on the natural law; it's on a specific, inventive *application* of that law. This invention has a much better chance of being patentable. The landmark supreme_court_of_the_united_states case, Mayo Collaborative Services v. Prometheus Laboratories, Inc., is all about drawing that critical line. It established a powerful two-part test to determine whether an invention that uses a law of nature is a genuinely new application or just an attempt to monopolize the law of nature itself. For inventors, scientists, and tech companies, especially in the fields of medicine and software, understanding this case isn't just academic—it's the key to protecting (or not being able to protect) their most valuable discoveries.

• Key Takeaways At-a-Glance:
• The Core Ruling: The Supreme Court unanimously ruled in Mayo v. Prometheus that you cannot patent a natural law and then simply add a step telling people to “apply it” using conventional methods.
• The Impact on You: If you are an inventor, this decision means your invention must include an “inventive concept” that goes significantly beyond the discovery of a natural correlation, especially for intellectual_property in medical diagnostics and software. patent_law.
• The Critical Action: To secure a patent for an invention involving a natural law, you must prove that your process contains inventive steps that transform the law into a new and useful application, not just observe it. uspto.

The story of Mayo v. Prometheus doesn't begin in a lab, but in the u.s._constitution. The founders gave Congress the power “To promote the Progress of Science and useful Arts, by securing for limited Times to Authors and Inventors the exclusive Right to their respective Writings and Discoveries.” This is the bedrock of American patent law. Congress used this power to create the patent_act_of_1952, the modern law governing patents. The most important part for our story is Section 101 (`35_u.s.c._101`), which defines what can be patented. But for over 150 years, the courts have recognized that this power has limits. They created three major exceptions to patentability, reasoning that some things are so fundamental that no one person can own them:

• Laws of Nature: Think E=mc² or the law of gravity.
• Natural Phenomena: A newly discovered plant in the Amazon or a new mineral.
• Abstract Ideas: Mathematical formulas or a method of organizing a business.

These are the basic tools of scientific and technological work. The courts feared that allowing patents on these “building blocks” would stifle innovation, not promote it. For decades, the line between a patent-ineligible law of nature and a patentable *application* of that law was a legal battlefield. Companies that discovered, for example, a correlation between a certain gene and a disease wanted to patent diagnostic tests based on that discovery. Was that patenting the law of nature itself, or a new invention? This tension set the stage for a major showdown at the Supreme Court.

The entire controversy revolves around one crucial sentence in U.S. law, 35_u.s.c._101:

“Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title.”

Let's break that down in plain language:

• Process: A series of steps to do or make something (like a method for synthesizing a chemical).
• Machine: A device with moving parts or circuitry (like a new type of engine).
• Manufacture: A physical product made from raw materials (like a new type of biodegradable plastic).
• Composition of Matter: A new chemical compound or mixture (like a new drug).

Prometheus's patent was for a “process.” The question for the Court was whether their process was a truly new and useful invention, or just a description of a law of nature with the words “apply it” tacked on at the end.

The legal journey of this case shows just how confusing this area of law had become. Prometheus Laboratories owned patents covering a method to help doctors using thiopurine drugs to treat autoimmune diseases. The discovery was simple: patients with too many drug metabolites in their blood were at risk of harmful side effects, while those with too few weren't getting an effective dose. The patent claimed a process of (a) administering the drug and (b) measuring the metabolite levels to determine if the dosage was correct. Mayo Clinic began using its own, similar test. Prometheus sued for patent_infringement. This kicked off a multi-year legal tug-of-war.

This back-and-forth created massive uncertainty. The country's top patent court and the lower courts disagreed fundamentally. The Supreme Court had no choice but to step in and provide a clear, final answer.

In a unanimous 9-0 decision delivered by Justice Breyer, the Supreme Court reversed the Federal Circuit and declared Prometheus's patents invalid. In doing so, it created a simple but powerful framework, now known as the Mayo Test, for analyzing these types of inventions.

The test is designed to distinguish patents that claim patent-ineligible concepts from those that genuinely integrate them into something new and useful.

First, a court must look at the patent claim_(legal) and ask: “At its core, is this claim about a law of nature, a natural phenomenon, or an abstract idea?” In the *Mayo* case, the answer was a clear yes. The core of Prometheus's patent was the newly discovered natural correlation between thiopurine metabolite levels and the drug's efficacy and toxicity. This is a law of nature—a fact about how the human body works. The patent claims were fundamentally based on this biological relationship. This first step acts as a filter. If the claim isn't directed to one of these three exceptions, the analysis can often stop there, and the claim is likely patent-eligible under Section 101. But if, like Prometheus's claims, it is, you must proceed to the critical second step.

If the claim is directed to a forbidden concept, the next question is: “What else is in the claim?” The court must search for an “inventive concept” by asking if the claim as a whole amounts to “significantly more” than the natural law itself. This is the heart of the *Mayo* decision. The “something more” cannot be just anything. The Court was very specific about what *doesn't* count:

• “Well-understood, routine, conventional activity”: Simply adding steps that any doctor or scientist in the field would already know how to do is not enough.
• “Post-solution activity”: You can't just state the law of nature and then add a generic instruction like “now apply it.”
• “Insignificant” additions: Adding a basic data-gathering step or a simple mental conclusion is not an inventive concept.

The Supreme Court looked at Prometheus's patent claims and broke them down:

1.  **The "administering" step:** This just told doctors to give a drug they were already giving. It was a pre-existing, conventional activity.
2.  **The "determining" step:** This instructed doctors to measure the metabolite levels. The Court noted that the methods for measuring these levels were already well-known in the field. This was also routine.
3.  **The "wherein" clause:** This part simply told the doctor to think about the natural law—"if the level is X, then increase the dose." This was just a mental step.

The Court concluded that “to transform an unpatentable law of nature into a patent-eligible *application* of such a law, one must do more than simply state the law of nature while adding the words 'apply it.'” The patent claims lacked any true inventive concept; they were just an attempt to own the discovery of the natural correlation itself.

The *Mayo* decision sent shockwaves through the worlds of medical diagnostics, personalized medicine, and software development. For decades, companies had been patenting diagnostic methods similar to Prometheus's. Overnight, the rules changed. This section is a practical playbook for understanding what *Mayo* means for you.

If you have an invention that relies on a newly discovered scientific principle or algorithm, you must analyze it through the lens of the *Mayo* test.

1. Be brutally honest. Is the heart of your invention a newly discovered biological correlation (e.g., “Gene X is associated with Disease Y”)? Is it a mathematical formula? Is it a fundamental economic principle? If so, you are squarely in *Mayo* territory.

1. What have you added to that core concept? Don't list the obvious. List what is genuinely new. Did you invent a completely new way to test for Gene X that is faster and more reliable than any existing method? Did you create a new machine that physically implements your mathematical formula in a way no one has before?
2. Example: Discovering that a certain protein indicates cancer is a law of nature. But inventing a new antibody that specifically and uniquely binds to that protein for use in a diagnostic kit could be a patentable “composition of matter” and a new “process.”

1. This is where most patents fail the *Mayo* test. Analyze every step you added beyond the core concept. Are these steps “well-understood, routine, conventional”?
2. Ask yourself: “In the year I filed my patent, would a skilled person in my field consider this step to be standard practice?”
3. If your only “extra” steps are things like “gather data” using a standard computer, “perform a measurement” using off-the-shelf lab equipment, or “display the result,” your patent is at high risk of being found invalid under *Mayo*.

1. When drafting a patent_application, especially the claims, the focus must be on the specific, concrete, and non-routine *application* of the discovery.
2. Weak Claim: “A method for treating disease Y, comprising: a) testing a patient for Gene X, and b) administering Drug Z if Gene X is present.” (This is likely invalid under *Mayo*).
3. Stronger Claim: “A method for treating disease Y, comprising: a) contacting a blood sample with our newly invented Compound A, which binds only to the protein expressed by Gene X; b) detecting the binding using a novel laser-based apparatus configured to…; and c) administering Drug Z.” (This focuses on new tools and machines, not just the natural law).

• Patent_Application: The formal document filed with the uspto to obtain a patent. It includes a detailed description of the invention (the “specification”) and the legal definition of the invention (the “claims”).
• The “Claims” Section: This is the most important part of a patent for the *Mayo* analysis. The claims are a series of numbered sentences at the end of the patent that define the precise legal boundaries of the invention. It is the language of the claims, and only the claims, that a court will analyze using the two-step *Mayo* test. Getting the claim language right is the single most critical task for a patent attorney in a post-*Mayo* world.

• Mayo* was not decided in a vacuum. It is part of a long line of Supreme Court cases wrestling with the boundaries of patentability. Understanding these cases helps clarify why the Court ruled the way it did.

• The Backstory: An engineer at an oil company developed a new mathematical formula for calculating an “alarm limit” during a catalytic conversion process. He claimed a patent for the process of using his formula to update this alarm limit.
• The Legal Question: Can you patent a process that consists only of a mathematical algorithm and conventional “post-solution activity”?
• The Holding: The Supreme Court said no. The only novel part of the invention was the formula itself, which is an unpatentable abstract idea. Simply adding the step “adjust the alarm to the new number” was not enough to make the whole process patentable. *Flook* is a direct ancestor of *Mayo*'s reasoning.

• The Backstory: A genetic engineer for General Electric, Ananda Chakrabarty, developed a bacterium capable of breaking down crude oil, which he hoped to use for cleaning up oil spills. The uspto rejected his patent claim for the bacterium itself.
• The Legal Question: Is a living, human-made microorganism a patentable “manufacture” or “composition of matter”?
• The Holding: In a landmark 5-4 decision, the Supreme Court said yes. The Court famously stated that “anything under the sun that is made by man” is patentable. Chakrabarty's bacterium was not a “natural phenomenon” but a new creation with markedly different characteristics from any found in nature. This case established that life sciences innovations could be patented, setting the stage for the biotech revolution.

• The Backstory: Alice Corporation patented a computerized method for mitigating settlement risk—essentially acting as a third-party intermediary to ensure financial trades go through smoothly. CLS Bank used a similar system, and Alice sued for infringement.
• The Legal Question: Was Alice's patent, which was implemented on a generic computer, directed to a patent-ineligible “abstract idea”?
• The Holding: The Supreme Court, explicitly and forcefully adopting the two-step framework from *Mayo*, said yes, the patent is invalid.
  • Step 1: The Court found the core of the patent was the abstract idea of “intermediated settlement,” a fundamental economic practice.
  • Step 2: The Court found no “inventive concept.” Implementing the idea on a generic computer was not “significantly more.” It was just using a computer to do what it does best: process data.
• The Impact Today: This case is hugely important because it took the *Mayo* test from the world of life sciences and applied it directly to software and business method patents. The framework is now universally known as the “Mayo/Alice Test” and is the definitive standard for patent eligibility in the United States.

The *Mayo/Alice* framework has been highly controversial. Many inventors, biotech companies, and software developers argue that it has created immense uncertainty and has invalidated thousands of previously valid patents, chilling investment and innovation. They argue that the test is too subjective and that judges are improperly deciding what is “routine” or “conventional.” On the other side, many large tech companies and open-source advocates argue that the test is working as intended. They believe it correctly prevents companies from patenting basic building blocks of commerce and science, which frees up others to innovate without fear of being sued for infringing on an overly broad patent. This has led to a major push in Congress to rewrite Section 101 of the Patent Act. Proposed laws, such as the patent_eligibility_restoration_act, have aimed to effectively abolish the judicial exceptions and the *Mayo/Alice* test, making it much easier to patent diagnostics, software, and business methods. The debate is one of the most contentious issues in intellectual_property law today.

The principles laid down in *Mayo* are now being tested by the rise of Artificial Intelligence (AI) and Machine Learning. Consider these future-facing questions:

• AI-Discovered Correlations: If a sophisticated AI analyzes millions of medical records and discovers a new, non-obvious correlation between a set of biomarkers and early-stage Alzheimer's, is that correlation a “law of nature”? Does the fact that a machine, not a human, discovered it change the analysis?
• Inventive Concept in AI: If an inventor uses a standard AI model (a “conventional” tool) to find that correlation, can they get a patent by simply claiming “use the AI to find the correlation and then apply it”? Under a strict reading of *Mayo*, the answer is likely no. The inventive concept would have to be in a new AI architecture or a novel way of applying the results.
• Can AI be an Inventor? The uspto and courts are currently grappling with whether an AI system can be named as an inventor on a patent. This goes to the heart of what “invention” means and will have profound implications for the future of innovation.

The legacy of Mayo v. Prometheus is a legal framework that forces us to constantly ask a fundamental question: What is the difference between a basic discovery about how the world works and a genuine human invention? As technology continues to accelerate, the test it established will remain a central, and controversial, pillar of American patent law.

• 35_u.s.c._101: The section of U.S. patent law that defines the categories of inventions eligible for a patent.
• abstract_idea: One of the three judicial exceptions to patentability, often applied to business methods and software algorithms.
• alice_corp_v_cls_bank: The 2014 Supreme Court case that applied the *Mayo* test to abstract ideas, creating the “Mayo/Alice” framework.
• claim_(legal): The numbered sentences at the end of a patent that define the legal scope of the invention.
• federal_circuit: The specialized federal appellate court that hears all patent case appeals from U.S. District Courts.
• inventive_concept: The crucial element required by the *Mayo* test; an addition to a law of nature that is “significantly more” than the law itself.
• law_of_nature: A fundamental scientific principle or truth, such as gravity or a correlation between a substance and a biological reaction.
• natural_phenomenon: One of the three judicial exceptions to patentability, referring to things that exist in nature, like a newly discovered plant or mineral.
• patent: A government-granted exclusive right to an inventor to exclude others from making, using, or selling their invention for a limited time.
• patent_act_of_1952: The primary statute that governs patent law in the United States today.
• patent_infringement: The unauthorized making, using, selling, or importing of a patented invention.
• supreme_court_of_the_united_states: The highest court in the U.S. federal judiciary, which has the final say in interpreting laws.
• uspto: The U.S. Patent and Trademark Office, the federal agency responsible for examining and granting patents.

• patent_law
• intellectual_property
• 35_u.s.c._101
• alice_corp_v_cls_bank
• diamond_v_chakrabarty
• uspto
• supreme_court_of_the_united_states